Log in to save to my catalogue

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival...

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1032599399

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-[beta], IL-10 and Ki67

About this item

Full title

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-[beta], IL-10 and Ki67

Publisher

New York: Elsevier Limited

Journal title

Cancer epidemiology, 2010-05, Vol.34 (3), p.316

Language

English

Formats

Publication information

Publisher

New York: Elsevier Limited

More information

Scope and Contents

Contents

Background : The immune modulating molecules cyclooxygenase-2 (COX-2), transforming growth factor-β (TGF-β) and interleukin-10 (IL-10) have regulatory roles in cancer progression. There are conflicting data regarding the roles of these molecules in prostate cancer. To elucidate the prognostic impact of these proteins and provide information on prog...

Alternative Titles

Full title

COX-2 is overexpressed in primary prostate cancer with metastatic potential and may predict survival. A comparison study between COX-2, TGF-[beta], IL-10 and Ki67

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_proquest_journals_1032599399

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_journals_1032599399

Other Identifiers

ISSN

1877-7821

E-ISSN

1877-783X

DOI

10.1016/j.canep.2010.03.019

How to access this item